News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,514 Results
Type
Article (88922)
Company Profile (669)
Press Release (795903)
Multimedia
Podcasts (244)
Webinars (36)
Section
Business (233653)
Career Advice (4164)
Deals (40024)
Drug Delivery (181)
Drug Development (91773)
Employer Resources (207)
FDA (18593)
Job Trends (17497)
News (398875)
Policy (40022)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (60)
ADA (49)
Adcomms (42)
Allergies (211)
Alliances (56991)
ALS (242)
Alzheimer's disease (2006)
Antibody-drug conjugate (ADC) (585)
Approvals (18986)
Artificial intelligence (909)
ASCO (345)
Autoimmune disease (383)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (257)
Biotechnology (406)
Bladder cancer (215)
Brain cancer (86)
Breast cancer (860)
Cancer (6779)
Cardiovascular disease (570)
Career advice (3601)
Career pathing (53)
CAR-T (394)
CDC (77)
Celiac Disease (3)
Cell therapy (1104)
Cervical cancer (58)
Clinical research (79352)
Collaboration (2458)
Commercialization (1)
Company closure (8)
Compensation (1583)
Complete response letters (110)
COVID-19 (3046)
CRISPR (128)
C-suite (1359)
Cystic fibrosis (170)
Data (8963)
Decentralized trials (3)
Denatured (93)
Depression (204)
Dermatology (103)
Diabetes (727)
Diagnostics (7644)
Digital health (73)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (461)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (332)
Earnings (102555)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (138968)
Executive appointments (1225)
FDA (22848)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (2020)
Gene editing (279)
Generative AI (93)
Gene therapy (869)
GLP-1 (1299)
Government (5570)
Grass and pollen (8)
Guidances (426)
Healthcare (21275)
Hematology (198)
HIV (100)
Huntington's disease (70)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (119)
Immunology and inflammation (367)
Immuno-oncology (122)
Indications (225)
Infectious disease (3456)
Inflammatory bowel disease (246)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (332)
Interviews (822)
IPO (18014)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (24)
Labor market (126)
Layoffs (696)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (892)
Lymphoma (491)
Machine learning (70)
Management (68)
Manufacturing (1295)
Marketing (5)
MASH (231)
Medical affairs (1)
Medical device (15311)
Medtech (15498)
Mergers & acquisitions (23361)
Metabolic disorders (1875)
mRNA (279)
Multiple sclerosis (211)
NASH (24)
Neurodegenerative disease (531)
Neuropsychiatric disorders (132)
Neuroscience (3818)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5147)
Now hiring (84)
Obesity (890)
Opinion (381)
Ovarian cancer (252)
Pain (290)
Pancreatic cancer (375)
Parkinson's disease (430)
Partnered (42)
Patents (682)
Patient recruitment (820)
Peanut (72)
People (68192)
Pharmaceutical (99)
Pharmacy benefit managers (38)
Phase 1 (24521)
Phase 2 (34470)
Phase 3 (25919)
Pipeline (10295)
Policy (405)
Postmarket research (3560)
Preclinical (11005)
Press Release (72)
Prostate cancer (355)
Psychedelics (74)
Radiopharmaceuticals (379)
Rare diseases (1333)
Real estate (7463)
Recruiting (82)
Regulatory (30663)
Reports (77)
Research institute (2776)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (346)
Series B (251)
Service/supplier (20)
Sickle cell disease (133)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (148)
Vaccines (1337)
Venture capital (143)
Weight loss (607)
Women's health (147)
Worklife (25)
Date
Today (109)
Last 7 days (457)
Last 30 days (2338)
Last 365 days (33280)
2026 (18025)
2025 (33216)
2024 (37977)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (410)
Arkansas (16)
Asia (52431)
Australia (9216)
California (14681)
Canada (4130)
China (1644)
Colorado (633)
Connecticut (649)
Delaware (453)
Europe (120919)
Florida (2208)
Georgia (478)
Hawaii (4)
Idaho (70)
Illinois (1288)
India (109)
Indiana (673)
Iowa (26)
Japan (624)
Kansas (144)
Kentucky (58)
Louisiana (64)
Maine (89)
Maryland (1772)
Massachusetts (10748)
Michigan (427)
Minnesota (817)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (158)
New Hampshire (92)
New Jersey (3884)
New Mexico (35)
New York (3878)
North Carolina (1959)
North Dakota (11)
Northern California (7324)
Ohio (459)
Oklahoma (27)
Oregon (51)
Pennsylvania (2880)
Puerto Rico (33)
Rhode Island (55)
South America (1669)
South Carolina (90)
South Dakota (2)
Southern California (5784)
Tennessee (241)
Texas (2400)
United States (52499)
Utah (440)
Vermont (2)
Virginia (377)
Washington D.C. (89)
Washington State (1196)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 885,514 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
Obesity newcomer Kalohexis makes confidential IPO bid 3 months after spinoff
Kalohexis is working on peptide therapies, including one for obesity that could offer an alternative approach to the GLP-1s that currently dominate the weight loss space.
July 8, 2026
·
2 min read
·
Tristan Manalac
Immunology and inflammation
AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical
In AstraZeneca’s third trip to Asia this year, the pharma secured ex-China rights to a dual inhibitor of PDE3 and PDE4, which in a Phase 2b study significantly improved lung function and lowered symptom burden in patients with chronic obstructive pulmonary disorder.
July 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia
July 8, 2026
·
3 min read
Press Releases
WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year
July 8, 2026
·
4 min read
Press Releases
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
July 8, 2026
·
4 min read
Press Releases
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
July 8, 2026
·
5 min read
Podcast
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
A surprising deal from Vertex Pharmaceuticals adds to Big Pharma’s acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked companies. Plus, FDA decisions slow only slightly as the hunt for a permanent leader drags on.
July 8, 2026
·
1 min read
·
Jef Akst
Venture capital
5 largest VC rounds of H1 2026
Early-stage financing rounds are on track to hit their lowest dollar value in years as funders continue to eschew risky investments, experts told
BioSpace
.
July 8, 2026
·
9 min read
·
Tristan Manalac
Artificial intelligence
Secretive AI drug hunter Xaira dips toe into dealmaking with hunt for partners
A mostly black box since emerging with more than a billion dollars in hand, Xaira Therapeutics is slowly pulling back the curtain, revealing plans to find partners and validate its pipeline.
July 8, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
OTR Therapeutics Enters Strategic Collaboration with LG Chem to Accelerate Development of Novel Oncology Therapies
July 7, 2026
·
3 min read
1 of 88,552
Next
